Nipple-sparing mastectomy
- PMID: 19483564
- DOI: 10.1097/PRS.0b013e3181a64d94
Nipple-sparing mastectomy
Abstract
Background: The debate over nipple-sparing mastectomy continues to evolve. Over the past several years, it has become more widely accepted, especially in the setting of prophylactic mastectomy, but its role in the treatment of breast cancer has only recently been reexamined.
Methods: Two indications for the procedure are discussed: prophylactic, for the high-risk patient; and the more controversial topic, therapeutic nipple-sparing mastectomy, for the patient with breast cancer. A review of the literature suggests that certain breast cancers may be amenable to retaining the nipple if they meet specific oncologic criteria: tumor size 3 cm or less, at least 2 cm from the nipple, not multicentric, and with clinically negative nodes. Moreover, newer technologies such as magnetic resonance imaging and preoperative mammotome biopsy may make the procedure even safer in this setting. Practical and technical aspects of the procedure are discussed, including patient selection.
Results: The accumulating data from multiple series of nipple-sparing mastectomy show that properly screened patients have a low risk of local cancer recurrence, that recurrences occur rarely in the nipple, and that recurrences in the nipple can be managed by removing the nipple.
Conclusions: Despite continued controversy and the need for more long-term outcome data, nipple-sparing mastectomy is a procedure that is gaining increasing visibility and acceptance. Provided that certain oncologic and practical criteria are applied, it has the potential for allowing less invasive surgery and improved cosmetic outcomes without increased oncologic risk in appropriately selected patients.
Comment in
-
Nipple-sparing mastectomy: what is the best evidence for safety?Plast Reconstr Surg. 2009 Dec;124(6):2195-2197. doi: 10.1097/PRS.0b013e3181bcf654. Plast Reconstr Surg. 2009. PMID: 19952691 No abstract available.
-
Has the time come to change the breast-conserving treatment for skin and nipple-areola complex-sparing mastectomy?Plast Reconstr Surg. 2010 Mar;125(3):1043-4; author reply 1044-5. doi: 10.1097/PRS.0b013e3181cb685c. Plast Reconstr Surg. 2010. PMID: 20195136 No abstract available.
References
-
- Freeman BS. Subcutaneous mastectomy. Plast Reconstr Surg. 1962;30:676–682.
-
- Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340:77–84.
-
- Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 2001;93:1633–1637.
-
- McDonnell SK, Schaid DJ, Myers JL, et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol. 2001;19:3938–3943.
-
- Crowe JP. Nipple-sparing mastectomy: Technique and results of 54 procedures. Arch Surg. 2004;139:148–150.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
